Table 1 Clinical characteristics of patients and pathological characteristics of lesions.

From: Esophageal metal stent for malignant obstruction after prior radiotherapy

 

Low radial force group

51 cases in 45 patients

High radial force group

56 cases in 54 patients

P value

Age

68 (32–87)

66 (43–91)

0.686

Sex

Male

31 (68.9)

48 (88.9)

0.022

Female

14 (31.1)

6 (11.1)

Tumor location

Ce

0

1 (1.9)

0.341

Ut

9 (20.0)

4 (7.4)

Mt

12 (26.7)

18 (33.3)

Lt

11 (24.4)

19 (35.2)

Ae

11 (24.4)

10 (18.5)

Anastomosis

2 (4.4)

2 (3.7)

Macroscopic type

Type 1

7 (15.6)

3 (5.6)

0.296

Type 2

11 (24.4)

13 (24.1)

Type 3

13 (28.9)

23 (42.6)

Type 4

14 (31.1)

14 (25.9)

Type 5

0

1 (1.9)

Histological type

Squamous cell carcinoma

31

43

0.333

Adenocarcinoma

11

10

Unknown

3

1

Secondary cancer

Lung cancer

1 (2.2)

0

1

Breast cancer

1 (2.2)

0

Prior RT

Yes

13 (25.5)

11 (19.6)

0.495

No

38 (74.5)

45 (80.4)

Degree of stenosisa

Possible

48 (94.1)

47 (83.9)

0.128

Impossible

3 (5.9)

9 (16.1)

Stenosis length, cm

3 (1–13)

5 (2–15)

0.001

Stent length, cm

10 (8–15)

10 (7–15)

0.015

Follow-up period, month

3 (1–12.0)

2 (0.5*–12.5)

0.237

  1. Data are presented as median (range) or n (%).
  2. Quantitative data were compared using Mann–Whitney’s U test.
  3. Categorical data were compared using Fisher’s exact test.
  4. Ae, abdominal esophagus; Ce, cervical esophagus; Lt, lower thoracic esophagus; Mt, middle thoracic esophagus; Ut, upper thoracic esophagus.
  5. aStenosis was evaluated by an approximately 6 mm diameter nasal endoscope.
  6. *Adverse events of less than 1 month are included.